Fig. 1 (abstract O35).
From: Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium
Classification plots showing sensitivity (true positive rate, TPR) and false positive rate (FPR) by threshold for the baseline model only (with 95% pointwise confidence intervals of TPR and FPR for risk thresholds of 20%, 30%, 40% for risk of metastatic remnants after chemotherapy in testicular cancer patients)